Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Cui

Showing results (771-780 of 796) with videos related to

Pageof 80
Sort By:
JCI Insight|April 23, 2026
Versican regulating viscoelasticity drives pleural fibrosis via mechanotransductive signalingZi-Heng Jia, Xin-Liang He, Xiao-Lin Cui, et al.
European Journal of Cancer (Oxford, England : 1990)|June 8, 2017
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH studyIan Chau, Markus Peck-Radosavljevic, Christophe Borg, et al.
European Journal of Cancer (Oxford, England : 1990)|July 5, 2018
Corrigendum to 'Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study' [Eur J Canc 81 (2017) 17-25]Ian Chau, Markus Peck-Radosavljevic, Christophe Borg, et al.
Cellular & Molecular Biology Letters|April 23, 2026
Upregulated CCN1 from pleural mesothelial cells alters collagen I conformation and drives fibrosis via ITGB1/MAPK signalingXiao-Lin Cui, Lin-Jie Song, Qian Li, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 26, 2021
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort studyPo Ying Chia, Sean Wei Xiang Ong, Calvin J Chiew, et al.
The Lancet Regional Health. Western Pacific|November 8, 2021
Impact of Delta Variant and Vaccination on SARS-CoV-2 Secondary Attack Rate Among Household Close ContactsOon Tek Ng, Vanessa Koh, Calvin J Chiew, et al.
JAMA|April 15, 2010
2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in SingaporeMark I C Chen, Vernon J M Lee, Wei-Yen Lim, et al.
Transboundary and Emerging Diseases|June 13, 2020
Clinical course and treatment efficacy of COVID-19 near Hubei Province, China: A multicentre, retrospective studyQing-Lei Zeng, Guang-Ming Li, Fanpu Ji, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|August 15, 2025
An Ile to Met polymorphism in ADCY9 promotes airway obstruction and remodeling in asthmaLi-Mei Liang, Peng-Cheng Cai, Fan Yu, et al.
Lancet (London, England)|March 21, 2020
Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measuresRachael Pung, Calvin J Chiew, Barnaby E Young, et al.
Pageof 80

Showing results (771-780 of 796) with videos related to

Sort By:
Pageof 80
JCI Insight|April 23, 2026
Versican regulating viscoelasticity drives pleural fibrosis via mechanotransductive signalingZi-Heng Jia, Xin-Liang He, Xiao-Lin Cui, et al.
European Journal of Cancer (Oxford, England : 1990)|June 8, 2017
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH studyIan Chau, Markus Peck-Radosavljevic, Christophe Borg, et al.
European Journal of Cancer (Oxford, England : 1990)|July 5, 2018
Corrigendum to 'Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study' [Eur J Canc 81 (2017) 17-25]Ian Chau, Markus Peck-Radosavljevic, Christophe Borg, et al.
Cellular & Molecular Biology Letters|April 23, 2026
Upregulated CCN1 from pleural mesothelial cells alters collagen I conformation and drives fibrosis via ITGB1/MAPK signalingXiao-Lin Cui, Lin-Jie Song, Qian Li, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 26, 2021
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort studyPo Ying Chia, Sean Wei Xiang Ong, Calvin J Chiew, et al.
The Lancet Regional Health. Western Pacific|November 8, 2021
Impact of Delta Variant and Vaccination on SARS-CoV-2 Secondary Attack Rate Among Household Close ContactsOon Tek Ng, Vanessa Koh, Calvin J Chiew, et al.
JAMA|April 15, 2010
2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in SingaporeMark I C Chen, Vernon J M Lee, Wei-Yen Lim, et al.
Transboundary and Emerging Diseases|June 13, 2020
Clinical course and treatment efficacy of COVID-19 near Hubei Province, China: A multicentre, retrospective studyQing-Lei Zeng, Guang-Ming Li, Fanpu Ji, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|August 15, 2025
An Ile to Met polymorphism in ADCY9 promotes airway obstruction and remodeling in asthmaLi-Mei Liang, Peng-Cheng Cai, Fan Yu, et al.
Lancet (London, England)|March 21, 2020
Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measuresRachael Pung, Calvin J Chiew, Barnaby E Young, et al.
Pageof 80